Terms: = Breast cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523
328 results:
1. Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in breast cancer Cells.
Cottrell KA; Ryu S; Pierce JR; Soto Torres L; Bohlin HE; Schab AM; Weber JD
Cancer Res Commun; 2024 Apr; 4(4):986-1003. PubMed ID: 38530197
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the experiences of women living with metastatic breast cancer [MBC]: A systematic review of qualitative evidence.
Lyons-Rahilly T; Meskell P; Carey E; Meade E; O' Sullivan D; Coffey A
PLoS One; 2024; 19(1):e0296384. PubMed ID: 38181009
[TBL] [Abstract] [Full Text] [Related]
3. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants.
Zhao S; Miao M; Wang Q; Zhao H; Yang H; Wang X
BMC Cancer; 2024 Jan; 24(1):30. PubMed ID: 38166779
[TBL] [Abstract] [Full Text] [Related]
4. Mutational and expressional association of the PIK3CA gene with the risk of breast cancer in the Pakistani population.
Abbasi SA; Khan R; Ahmed MN; Hussain K; Riaz A; Mansoor Q; Qayyum M; Mehmood Baig R
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):1-8. PubMed ID: 38015548
[TBL] [Abstract] [Full Text] [Related]
5. Thymus Vulgaris Oil Nanoemulsion: Synthesis, Characterization, Antimicrobial and Anticancer Activities.
Doghish AS; Shehabeldine AM; El-Mahdy HA; Hassanin MMH; Al-Askar AA; Marey SA; AbdElgawad H; Hashem AH
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836753
[TBL] [Abstract] [Full Text] [Related]
6. Axillary Treatment and Chronic breast cancer-Related Lymphedema: Implications for Prospective Surveillance and Intervention From a Randomized Controlled Trial.
Boyages J; Vicini FA; Manavi BA; Gaw RL; Koelmeyer LA; Ridner SH; Shah C
JCO Oncol Pract; 2023 Dec; 19(12):1116-1124. PubMed ID: 37816208
[TBL] [Abstract] [Full Text] [Related]
7. Doxorubicin-loaded Niosomes functionalized with gelatine and alginate as pH-responsive drug delivery system: A 3D printing approach.
Zaer M; Moeinzadeh A; Abolhassani H; Rostami N; Tavakkoli Yaraki M; Seyedi SA; Nabipoorashrafi SA; Bashiri Z; Moeinabadi-Bidgoli K; Moradbeygi F; Farmani AR; Hossein-Khannazer N
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126808. PubMed ID: 37689301
[TBL] [Abstract] [Full Text] [Related]
8. Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene.
Corso G; Marabelli M; Calvello M; Gandini S; Risti M; Feroce I; Mannucci S; Girardi A; De Scalzi AM; Magnoni F; Marino E; Bernard L; Veronesi P; Guerini-Rocco E; Barberis M; Guerrieri-Gonzaga A; Bonanni B
Eur J Hum Genet; 2023 Nov; 31(11):1275-1282. PubMed ID: 37460658
[TBL] [Abstract] [Full Text] [Related]
9. Involvement of AKT/PI3K Pathway in Sanguinarine's Induced Apoptosis and Cell Cycle Arrest in Triple-negative breast cancer Cells.
Messeha SS; Noel S; Zarmouh NO; Womble T; Latinwo LM; Soliman KFA
Cancer Genomics Proteomics; 2023; 20(4):323-342. PubMed ID: 37400144
[TBL] [Abstract] [Full Text] [Related]
10. What radiolabeled FAPI pet can add in breast cancer? A systematic review from literature.
Evangelista L; Filippi L; Schillaci O
Ann Nucl Med; 2023 Aug; 37(8):442-450. PubMed ID: 37341971
[TBL] [Abstract] [Full Text] [Related]
11. Treatment burden in individuals living with and beyond cancer: A systematic review of qualitative literature.
Adam R; Nair R; Duncan LF; Yeoh E; Chan J; Vilenskaya V; Gallacher KI
PLoS One; 2023; 18(5):e0286308. PubMed ID: 37228101
[TBL] [Abstract] [Full Text] [Related]
12. 3D-printing-assisted synthesis of paclitaxel-loaded niosomes functionalized by cross-linked gelatin/alginate composite: Large-scale synthesis and in-vitro anti-cancer evaluation.
Hosseini F; Mirzaei Chegeni M; Bidaki A; Zaer M; Abolhassani H; Seyedi SA; Nabipoorashrafi SA; Ashrafnia Menarbazari A; Moeinzadeh A; Farmani AR; Tavakkoli Yaraki M
Int J Biol Macromol; 2023 Jul; 242(Pt 1):124697. PubMed ID: 37156313
[TBL] [Abstract] [Full Text] [Related]
13. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing RB1 expression.
Zhang Y; He B; Zhang D; Zhang Y; Chen C; Zhang W; Yang S; Yao M; Cui G; Gu J; Wang T; Lin Z; Fan Y; Xiong Z; Hao Y
Cell Rep; 2023 Mar; 42(3):112188. PubMed ID: 36857183
[TBL] [Abstract] [Full Text] [Related]
14. Psychosocial experiences of breast cancer survivors: a meta-review.
R K; L S; P B; S G; R LP
J Cancer Surviv; 2024 Feb; 18(1):84-123. PubMed ID: 36854799
[TBL] [Abstract] [Full Text] [Related]
15. Effects of scapulothoracic stabilization exercises on scapular function, posture, and balance in lymphedema after mastectomy: a randomized controlled trial.
Pirincci CS; Dalyan M; Delialioglu SU; Celenay ST
Women Health; 2023 Apr; 63(4):251-265. PubMed ID: 36814100
[TBL] [Abstract] [Full Text] [Related]
16. MCF-7 cells lack the expression of caspase-3.
Tian T
Int J Biol Macromol; 2023 Mar; 231():123310. PubMed ID: 36690238
[TBL] [Abstract] [Full Text] [Related]
17. Pharmacokinetics and Pharmacodynamic of Alpelisib.
Royer B; Kaderbhaï CG; Schmitt A
Clin Pharmacokinet; 2023 Jan; 62(1):45-53. PubMed ID: 36633813
[TBL] [Abstract] [Full Text] [Related]
18. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
[TBL] [Abstract] [Full Text] [Related]
19. Whole-exome sequencing of BRCA-negative breast cancer patients and case-control analyses identify variants associated with breast cancer susceptibility.
Lee NY; Hum M; Amali AA; Lim WK; Wong M; Myint MK; Tay RJ; Ong PY; Samol J; Lim CW; Ang P; Tan MH; Lee SC; Lee ASG
Hum Genomics; 2022 Nov; 16(1):61. PubMed ID: 36424660
[TBL] [Abstract] [Full Text] [Related]
20. Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liao B; Liu Z
Int J Biol Sci; 2022; 18(15):5963-5977. PubMed ID: 36263167
[TBL] [Abstract] [Full Text] [Related]
[Next]
